BOSTON--(BUSINESS WIRE)--Ensoma, an in vivo hematopoietic stem cell (HSC) engineering company with a mission to advance the future of medicine through one-time therapies, today announced the closing ...
The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising ...
Funded by the UB Provost, the new Center for Cell, Gene and Tissue Engineering (CGTE) will be led by SUNY Distinguished Professor Stelios Andreadis. “I am very happy to announce the launch of the Cell ...
Scientists at the University of Osaka have developed a novel hydrogel that enables the efficient, three-dimensional (3D) ...
A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to ...
Key opportunities in the U.S. regenerative medicine market include the rising adoption of stem cell technology and a strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback